Ranger Investment Management L.P. Takes Position in Stevanato Group S.p.A. (NYSE:STVN)

Ranger Investment Management L.P. bought a new position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 593,860 shares of the company's stock, valued at approximately $12,940,000. Ranger Investment Management L.P. owned 0.20% of Stevanato Group at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. M&T Bank Corp acquired a new position in Stevanato Group during the fourth quarter worth about $572,000. Mutual of America Capital Management LLC purchased a new stake in shares of Stevanato Group during the fourth quarter worth about $13,848,000. Advantage Alpha Capital Partners LP raised its position in shares of Stevanato Group by 27.3% in the fourth quarter. Advantage Alpha Capital Partners LP now owns 293,865 shares of the company's stock valued at $6,403,000 after buying an additional 63,041 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Stevanato Group by 4.5% during the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company's stock valued at $53,872,000 after buying an additional 115,050 shares during the period. Finally, Allianz SE acquired a new stake in Stevanato Group during the fourth quarter worth approximately $748,000.

Stevanato Group Stock Performance

NYSE:STVN traded up €0.07 ($0.08) during midday trading on Monday, reaching €21.98 ($24.98). 75,248 shares of the company traded hands, compared to its average volume of 354,304. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm has a market capitalization of $6.66 billion, a price-to-earnings ratio of 46.77, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.82) and a twelve month high of €29.81 ($33.88). The company has a fifty day moving average price of €20.50 and a 200 day moving average price of €20.63.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share (EPS) for the quarter, meeting the consensus estimate of €0.20 ($0.23). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million during the quarter, compared to analysts' expectations of €346.26 million. On average, analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on STVN. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. UBS Group decreased their price target on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a report on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($29.20).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.